BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BellBrook Labs LLC Announces Kinase/ATPase detection that is "2" sensitive


10/21/2008 10:00:03 AM

This "next generation" ADP detection assay offers improved sensitivity and increased flexibility over the original ADP detection assay, making it the most sensitive tool for high throughput screening and selectivity profiling of ADP-producing enzymes.The first generation Transcreener ADP assay was a game changer because it allowed generic detection of any enzyme that converts ATP to ADP without the use of coupling enzymes such as luciferase. This assay enabled the facile detection and screening of established drug targets including protein and lipid kinases as wells as emerging targets such as heat shock proteins and other ATPases. The assay relied on a highly selective antibody that specifically recognizes ADP even in the presence of much higher ATP concentrations, allowing the screening of diverse enzymes with native and synthetic substrates or enzymes with intrinsic ATPase activity (without substrate) - all with the same set of reagents . Now BellBrook Labs has developed an improved monoclonal antibody that allows more sensitive ADP detection and increases the total assay signal. This means that you can get a very good assay window (Z’ = 0.7) using ATP concentrations as low as 100nM or as high as 1mM under initial velocity conditions (=10% substrate conversion).


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES